Search Orphan Drug Designations and Approvals
-
Generic Name: | small molecule composed of a ligand binding moiety to BRD9, a chemical linker, and a ligand binding moiety to the cereblon (CRBN) E3 ligase |
---|---|
Date Designated: | 03/08/2022 |
Orphan Designation: | Treatment of Soft Tissue Sarcoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
C4 Therapeutics, Inc. 490 Arsenal Way Suite 200 Watertown, Massachusetts 02742 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-